Beijing Andawell Science & Technology Co., Ltd.
SZSE:300719.SZ
12.96 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 850.861 | 412.546 | 475.457 | 609.7 | 552.447 | 499.375 | 439.816 | 397.704 | 311.28 | 296.154 | 311.037 |
| Cost of Revenue
| 455.46 | 248.858 | 253.984 | 299.659 | 255.416 | 248.583 | 203.753 | 170.782 | 135.666 | 119.739 | 114.79 |
| Gross Profit
| 395.401 | 163.689 | 221.473 | 310.041 | 297.031 | 250.792 | 236.063 | 226.922 | 175.613 | 176.415 | 196.247 |
| Gross Profit Ratio
| 0.465 | 0.397 | 0.466 | 0.509 | 0.538 | 0.502 | 0.537 | 0.571 | 0.564 | 0.596 | 0.631 |
| Reseach & Development Expenses
| 66.679 | 69.486 | 70.157 | 83.676 | 69.507 | 58.044 | 39.345 | 25.096 | 21.085 | 14.567 | 14.336 |
| General & Administrative Expenses
| 32.652 | 29.026 | 31.702 | 26.918 | 34.208 | 28.04 | 21.806 | 14.725 | 13.112 | 11.01 | 64.412 |
| Selling & Marketing Expenses
| 33.841 | 27.145 | 27.477 | 28.379 | 26.831 | 39.403 | 30.083 | 30.6 | 24.71 | 22.79 | 25.157 |
| SG&A
| 66.493 | 56.171 | 59.179 | 55.297 | 61.039 | 67.442 | 51.889 | 45.325 | 37.822 | 33.8 | 89.569 |
| Other Expenses
| -725.507 | -0.516 | -0.346 | -1.804 | -0.486 | 3.391 | -0.016 | 21.729 | 32.724 | 15.657 | 9.102 |
| Operating Expenses
| 725.507 | 205.004 | 211.951 | 186.019 | 206.276 | 197.392 | 118.828 | 131.737 | 106.904 | 94.733 | 93.568 |
| Operating Income
| 125.354 | -62.068 | 4.684 | 104.789 | 83.029 | 57.579 | 102.617 | 83.947 | 52.027 | 67.582 | 93.017 |
| Operating Income Ratio
| 0.147 | -0.15 | 0.01 | 0.172 | 0.15 | 0.115 | 0.233 | 0.211 | 0.167 | 0.228 | 0.299 |
| Total Other Income Expenses Net
| -0.443 | -0.516 | -0.346 | -1.804 | -0.486 | 3.391 | -0.016 | 21.617 | 32.647 | 7.117 | 8.682 |
| Income Before Tax
| 124.911 | -62.583 | 4.337 | 102.985 | 82.543 | 60.971 | 102.601 | 105.564 | 84.674 | 74.699 | 101.699 |
| Income Before Tax Ratio
| 0.147 | -0.152 | 0.009 | 0.169 | 0.149 | 0.122 | 0.233 | 0.265 | 0.272 | 0.252 | 0.327 |
| Income Tax Expense
| 11.414 | -16.768 | -6.088 | 7.507 | 9.394 | 5.53 | 12.806 | 14.38 | 13.183 | 14.812 | 16.834 |
| Net Income
| 113.48 | -45.815 | 10.426 | 95.478 | 73.149 | 55.441 | 89.794 | 91.184 | 53.711 | 44.064 | 67.022 |
| Net Income Ratio
| 0.133 | -0.111 | 0.022 | 0.157 | 0.132 | 0.111 | 0.204 | 0.229 | 0.173 | 0.149 | 0.215 |
| EPS
| 0.45 | -0.18 | 0.041 | 0.38 | 0.29 | 0.22 | 0.31 | 0.49 | 2.68 | 2.2 | 0 |
| EPS Diluted
| 0.45 | -0.18 | 0.041 | 0.38 | 0.29 | 0.22 | 0.31 | 0.49 | 2.68 | 2.2 | 0 |
| EBITDA
| 179.505 | -16.869 | 30.465 | 137.62 | 107.059 | 74.025 | 127.812 | 125.925 | 110.248 | 97.305 | 112.785 |
| EBITDA Ratio
| 0.211 | -0.041 | 0.064 | 0.226 | 0.194 | 0.148 | 0.291 | 0.317 | 0.354 | 0.329 | 0.363 |